Drug shortage
Amphetamine Aspartate Monohydrate · Lannett Company, Inc.
FDA drug shortage · Current · updated Apr 17, 2025
Key facts
| Generic name | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet |
|---|---|
| Proprietary name | Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate |
| Company | Lannett Company, Inc. |
| Presentation | Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0527-0761-37) |
| Dosage form | Tablet |
| Strength | 1.875 mg |
| Status | Current |
| Therapeutic category | Psychiatry |
| Package NDCs | 0527-0761-37 |
| First posted | Oct 12, 2022 |
| Last updated | Apr 17, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: